Intellia Therapeutics Head office building

SEC Filing
Details

Document Details

Form
Filing Date
Feb 26, 2024
Document Date
Feb 26, 2024
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
Intellia Therapeutics
Issuer
Intellia Therapeutics, Inc.